Asthma control and future asthma-related morbidity in inner-city asthmatic children

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 2, 2008, Pages 144-152

  Kwong, Kenny Y C ^a,d   Morphew, Tricia ^b   Scott, Lyne ^a   Guterman, Jeffrey ^c   Jones, Craig A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Southern California Chapter of the Asthma and Allergy Foundation of America   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CITY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK; RISK REDUCTION;

EID: 49449095707     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60202-5     Document Type: Article

References (18)

1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3). Bethesda, MD: National Heart, Lung, and Blood Institute; 2007. NIH publication 08-4051.
2. Dolan CM, Fraher KE, Bleecker ER, et al; TENOR Study Group. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92:32-39.
3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002. NIH publication 02-3659.
4. Jones CA, Clement LT, Morphew T, et al. Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program. J Allergy Clin Immunol. 2007;119:1445-1453.
5. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051.
6. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002. NIH publication 02-5074.
7. 2-agonists. J Pediatr. 2006;148:517-521.
8. 2-agonists alone. J Allergy Clin Immunol. 2003;112:1088-1094.
9. Naqvi M, Choudhry S, Tsai HJ, et al. Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma. J Allergy Clin Immunol. 2007;120:137-143.
10. van Dellen QM, Stronks K, Bindels PJ, Ory FG, Bruil J, van Aalderen WM; PEACE Study Group. Predictors of asthma control in children from different ethnic origins living in Amsterdam. Respir Med. 2007;101:779-785.
11. Wechsler ME, Lehman E, Lazarus SC, et al; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. β-Adrenergic receptor polymorphism and response to salmeterol. Am J Respir Crit Care Med. 2006;173:519-526.
12. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled steroids. Hum Mol Genet. 2004;13:1353-1359.
13. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996;154:654-660.
14. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol. 2005;116:267-273.
15. Cerasoli F Jr. Developing the ideal inhaled steroid. Chest. 2006;130(suppl):54S-64S.
16. Todd GR. GOAL: asthma control, but at what cost? Am J Respir Crit Care Med. 2005;172:254-255.
17. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? the Gaining Optimal Asthma Control study. Am J Respir Crit Care Med. 2004;170:836-844.
18. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007;119:1454-1461.